Find out more about our Academic Medical Centre and efforts in Academic Medicine
Academic Medicine Executive Committee (AM EXCO)
Find out more about what JOAM do to support AM initiatives
Find out more about the Office of Duke-NUS Affairs and ACP Study Trip to Duke Durham
Guidelines, forms, and templates for Academic Medicine.
Retinopathy of Prematurity (ROP) is a disorder of the eye that occurs in premature babies. It is caused by the abnormal development of blood vessels in the retina (the tissue that lines the back of the eye) of an immature eye. When severe, these abnormal blood vessels can leak and pull on the retina (the thin photosensitive layer at the back of the eye), resulting in a retinal detachment and visual loss.
Generally, there are no symptoms in the early stages of ROP. In severe stages, vision can be affected and hence screening is important as babies will not be able to report any symptoms.
ROP only occurs in premature babies and in Singapore, babies younger than 32 weeks and smaller than 1500g will require regular eye screening during the first few months of life. Careful monitoring and optimization of oxygen levels may also reduce the risk of severe ROP. Screening is important as treatment when required, can reduce the risk of progression to more severe disease and visual loss.
Babies born before 32 weeks of gestation with a birth weight of less than 1500g are at risk of developing ROP. The smaller the baby is at birth, the higher the risk of developing ROP. Other concurrent medical conditions and fluctuations in oxygen supplementation can also increase this risk.
The presence, severity and extend of ROP is determined by clinical examination via a dilated retinal examination.
Treatment for ROP depends on the severity and extent of ROP. This is described in stages 1-5 (stage 1 being the least severe and 5 being the most severe), and in zones (zone 1 is the closest to the centre of the retina and zone 3 is the furthest).